AARD vs GILD: Which Stock is Better?
Side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and Gilead Sciences Inc in 2026
AARD
Aardvark Therapeutics, Inc. Common Stock
—
GILD
Gilead Sciences Inc
$129.16
Key Metrics Comparison
| Metric | AARD | GILD | Winner |
|---|---|---|---|
| Market Cap | $284.41M | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze AARD
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AARD or GILD a better investment?
Comparing AARD and GILD: Aardvark Therapeutics, Inc. Common Stock has a market cap of $284.41M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AARD and GILD?
AARD (Aardvark Therapeutics, Inc. Common Stock) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AARD or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AARD or GILD?
Both AARD and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: AARD or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: AARD or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $284.41M for AARD.
Should I buy AARD or GILD in 2026?
Both AARD and GILD have investment merit. AARD trades at $N/A while GILD trades at $129.16. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AARD and GILD stock?
Key differences: Market Cap ($284.41M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy AARD or GILD in 2026?
The choice between AARD and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between AARD and GILD?
AARD (Aardvark Therapeutics, Inc. Common Stock) has a market cap of $284.41M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.